PAVM logo

PAVM
PAVmed Inc

9,282
Mkt Cap
$58.98M
Volume
7,652.00
52W High
$28.44
52W Low
$6.00
PE Ratio
-0.40
PAVM Fundamentals
Price
$9.24
Prev Close
$9.75
Open
$9.52
50D MA
$9.93
Beta
1.12
Avg. Volume
18,518.93
EPS (Annual)
-$5.63
P/B
0.92
Rev/Employee
$1,731.71
$29.26
Loading...
Loading...
News
all
press releases
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual...
PR Newswire·3d ago
News Placeholder
More News
News Placeholder
PAVM Assigns Joseph Virgilio to Lead Medical Device Portfolio Relaunch
PAVmed taps industry veteran Joseph Virgilio to lead its device portfolio relaunch to boost growth, commercialization and long-term shareholder value.
Zacks·5d ago
News Placeholder
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio PR Newswire NEW YORK, April 2, 2026 Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical...
PR Newswire·10d ago
News Placeholder
PAVmed (PAVM) Upgraded to Buy: Here's What You Should Know
PAVmed (PAVM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·13d ago
News Placeholder
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results PR...
PR Newswire·13d ago
News Placeholder
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results Lucid Diagnostics Provides Business Update and Reports Fourth Quarter and Full Year 2025...
PR Newswire·17d ago
News Placeholder
PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026
PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 30, 2026 PAVmed to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and...
PR Newswire·27d ago
News Placeholder
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update...
PR Newswire·1mo ago
News Placeholder
What's Going On With PAVmed Shares Thursday?
PAVmed shares pull back Thursday, possibly retracing recent gains on news its subsidiary, Lucid Diagnostics secured a contractread more...
Benzinga·3mo ago
News Placeholder
Why Is PAVmed Stock Skyrocketing Wednesday?
PAVmed Inc. (PAVM) surges as its subsidiary Lucid Diagnostics (LUCD) secures a contract with VA for its cancer prevention test.read more...
Benzinga·3mo ago
<
1
2
...
>

Latest PAVM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.